Barrow, Hanley, Mewhinney & Strauss’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-23,201
| Closed | -$79K | – | 456 |
|
|
2017
Q3 | $79K | Sell |
23,201
-2,186
| -9% | -$7.44K | ﹤0.01% | 348 |
|
|
2017
Q2 | $63K | Hold |
25,387
| – | – | ﹤0.01% | 359 |
|
|
2017
Q1 | $58K | Sell |
25,387
-272,239
| -91% | -$622K | ﹤0.01% | 359 |
|
|
2016
Q4 | $631K | Sell |
297,626
-1,659
| -0.6% | -$3.52K | ﹤0.01% | 323 |
|
|
2016
Q3 | $1M | Buy |
299,285
+2,110
| +0.7% | +$7.07K | ﹤0.01% | 294 |
|
|
2016
Q2 | $933K | Sell |
297,175
-1,068
| -0.4% | -$3.35K | ﹤0.01% | 288 |
|
|
2016
Q1 | $993K | Buy |
298,243
+16,497
| +6% | +$54.9K | ﹤0.01% | 291 |
|
|
2015
Q4 | $997K | Buy |
281,746
+5,255
| +2% | +$18.6K | ﹤0.01% | 288 |
|
|
2015
Q3 | $1.39M | Hold |
276,491
| – | – | ﹤0.01% | 269 |
|
|
2015
Q2 | $1.78M | Buy |
276,491
+14,192
| +5% | +$91.3K | ﹤0.01% | 256 |
|
|
2015
Q1 | $1.85M | Buy |
+262,299
| New | +$1.85M | ﹤0.01% | 246 |
|